National cancer incidence and mortality in China, 2012

Wanqing Chen, Rongshou Zheng, Tingting Zuo, Hongmei Zeng, Siwei Zhang, Jie He

2016, 28(1): 1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer

Jun Zhao, Minglei Zhuo, Zhijie Wang, Jianchun Duan, Yuyan Wang, Shuhang Wang, Tongtong An, Meina Wu, Jie Wang

2016, 28(1): 12-18. doi: 10.3978/j.issn.1000-9604.2016.02.07

Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism

Wei Yang, Ming Cui, Jungchieh Lee, Wei Gong, Song Wang, Jingjing Fu, Gongxiong Wu, Kun Yan

2016, 28(1): 19-28. doi: 10.3978/j.issn.1000-9604.2016.02.06

Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas

Qiu Rao, Qiu-Yuan Xia, Liang Cheng, Xiao-Jun Zhou

2016, 28(1): 29-49. doi: 10.3978/j.issn.1000-9604.2016.01.03

The update of prostatic ductal adenocarcinoma

Tantan Liu, Yingmei Wang, Ru Zhou, Haiyang Li, Hong Cheng, Jing Zhang

2016, 28(1): 50-57. doi: 10.3978/j.issn.1000-9604.2016.02.02

The evolving Gleason grading system

Ni Chen, Qiao Zhou

2016, 28(1): 58-64. doi: 10.3978/j.issn.1000-9604.2016.02.04

PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer

Zheng Yang, Lu Yu, Zhe Wang

2016, 28(1): 65-71. doi: 10.3978/j.issn.1000-9604.2016.01.05

The benign mimickers of prostatic acinar adenocarcinoma

Yuqiao Xu, Yingmei Wang, Ru Zhou, Haiyang Li, Hong Cheng, Zhe Wang, Jing Zhang

2016, 28(1): 72-79. doi: 10.3978/j.issn.1000-9604.2016.01.01

Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview

Ming Zhao, Xiang-Lei He, Xiao-Dong Teng

2016, 28(1): 92-98. doi: 10.3978/j.issn.1000-9604.2016.02.05

Intraductal carcinoma of prostate (IDC-P): from obscure to significant

Ni Chen, Qiao Zhou

2016, 28(1): 99-106. doi: 10.3978/j.issn.1000-9604.2016.01.04

The pathology of urinary bladder lesions with an inverted growth pattern

Aitao Guo, Aijun Liu, Xiaodong Teng

2016, 28(1): 107-121. doi: 10.3978/j.issn.1000-9604.2016.02.01

Molecular aspects of prostate cancer with neuroendocrine differentiation

Qi Li, Connie S. Zhang, Yifen Zhang

2016, 28(1): 122-129. doi: 10.3978/j.issn.1000-9604.2016.01.02

The pathology of unusual subtypes of prostate cancer

Jing Li, Zhe Wang

2016, 28(1): 130-143. doi: 10.3978/j.issn.1000-9604.2016.01.06

Chinese version of NCCN Clinical Practice Guidelines in Oncology officially authorized by NCCN

Yanhua Zheng, Dingyao Xu, Zhaode Bu

2016, 28(1): 144-145. doi: 10.3978/j.issn.1000-9604.2016.02.10